Al-Wakeel Yasir B. Insider Trades

Insider Trading History

Track insider trading activity for Al-Wakeel Yasir B.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MaxCyte
MaxCyte MXCT
Director
Holding Value $60.9k 50,790 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$107k 50,790 shares
$2.11
$1.20
MaxCyte
MaxCyte MXCT
Director
Holding Value $48.8k 40,701 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$190k 40,701 shares
$4.68
$1.20
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $305k 346,102 shares
Last Trade
Jul 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.8k 9,617 shares
$1.75
$0.88
MaxCyte
MaxCyte MXCT
Director
Holding Value $60k 50,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$229k 50,000 shares
$4.57
$1.20
MaxCyte
MaxCyte MXCT
Director
Holding Value $48k 40,000 shares
Last Trade
Mar 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$168k 40,000 shares
$4.19
$1.20
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $313k 355,719 shares
Last Trade
Feb 24, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$15.7k 9,026 shares
$1.74
$0.88
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $321k 364,745 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$435k 208,367 shares
$2.09
$0.88
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $191k 216,841 shares
Last Trade
Jul 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 53,600 shares
$5.02
$0.88
MaxCyte
MaxCyte MXCT
Director
Holding Value $32.3k 26,900 shares
Last Trade
Jun 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.7M 26,900 shares
$63.30
$1.20
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $144k 163,241 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 80,000 shares
$7.08
$0.88
MaxCyte
MaxCyte MXCT
Director
Holding Value $12k 10,000 shares
Last Trade
Aug 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.20
MaxCyte
MaxCyte MXCT
Director
Holding Value $0 0 shares
Last Trade
Jul 29, 2021 Sale
No data
No data
$1.20
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $96.5k 109,641 shares
Last Trade
Dec 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.24M 72,422 shares
$30.94
$0.88
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $95.6k 108,633 shares
Last Trade
Dec 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.36M 108,633 shares
$30.94
$0.88
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $32.8k 37,219 shares
Last Trade
Oct 14, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$166k 5,250 shares
$31.57
$0.88
Kronos Bio
Kronos Bio KRON
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 08, 2020 Sale
No data
No data
$0.88
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
CFO And Head Of Corp Dev
Holding Value $1.59M 105,000 shares
Last Trade
Feb 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.06M 105,000 shares
$48.20
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
CFO And Head Of Corp Dev
Holding Value $4.54M 300,000 shares
Last Trade
Aug 11, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9M 300,000 shares
$89.63
$15.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up